# NON-GLP DOSE-RANGE FINDING AND GLP TOXICITY STUDIES AND IN VITRO DRUG-DRUG INTERACTION STUDIES FOR A SMALL PEPTIDE

> **NIH NIH N01** · BATTELLE CENTERS/PUB HLTH RES & EVALUATN · 2024 · $1,924,589

## Abstract

The BPN-Biologics Services Indefinite delivery, indefinite quantity (IDIQ) contract provides neuroscience product developers/innovators with a full range of industry-style, biologic drug-development services and expertise for their development of biological therapeutics for neurological diseases. These product developers/researchers are funded through other programs at the National Institutes of Health (NIH) but may lack the entire suite of capabilities necessary to advance their candidate product to a phase I clinical trial. Therefore, this contract augments the progress of the candidate product by providing the support required at the specific stage of its development and optimization path. The services offered through this contract are assay development, pharmacokinetics, manufacturing, formulation, fill-finish, investigational new drug (IND)-enabling toxicological studies, and support through phase I clinical trial.

## Key facts

- **NIH application ID:** 11212437
- **Project number:** 75N95022D00021-0-759502400002-1
- **Recipient organization:** BATTELLE CENTERS/PUB HLTH RES & EVALUATN
- **Principal Investigator:** KAITLIN PANG
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $1,924,589
- **Award type:** —
- **Project period:** 2024-03-26 → 2027-03-25

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11212437

## Citation

> US National Institutes of Health, RePORTER application 11212437, NON-GLP DOSE-RANGE FINDING AND GLP TOXICITY STUDIES AND IN VITRO DRUG-DRUG INTERACTION STUDIES FOR A SMALL PEPTIDE (75N95022D00021-0-759502400002-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11212437. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*